← Back to Search

Ex Vivo Lung Perfusion

EVLP Group for Lung Transplant

N/A
Waitlist Available
Research Sponsored by XVIVO Perfusion
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Recipient Inclusion/
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights

Study Summary

Human donor lungs that do not meet the standard clinical criteria for donor lung utilization but fit into the study inclusion criteria will be retrieved from the donor using current donor lung retrieval techniques.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
PAS Study Primary Endpoint
PMA Study Primary Endpoint
Secondary outcome measures
PAS Secondary Endpoint
PMA Secondary Endpoints

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: EVLP GroupExperimental Treatment1 Intervention
EVLP Group are those recipient lung transplant patients that received donor lungs that had been placed on the XPS™ with Steen Solution™ and undergone ex-vivo lung perfusion before being transplanted.
Group II: Control GroupActive Control1 Intervention
Control Group are those recipient lung transplant patients that receive donor lungs via conventional transplant.

Find a Location

Who is running the clinical trial?

XVIVO PerfusionLead Sponsor
8 Previous Clinical Trials
873 Total Patients Enrolled
1 Trials studying Lung Transplant
315 Patients Enrolled for Lung Transplant
Jaya Tiwari, BS, CCRPStudy DirectorXVIVO Perfusion, Inc
1 Previous Clinical Trials
315 Total Patients Enrolled
1 Trials studying Lung Transplant
315 Patients Enrolled for Lung Transplant

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Novel Lung Trial: Normothermic Ex Vivo Lung Perfusion (Evlp) As An Assessment Of Extended/Marginal Donor Lungs
2011. "Novel Lung Trial: Normothermic Ex Vivo Lung Perfusion (Evlp) As An Assessment Of Extended/Marginal Donor Lungs". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01365429.
All > Lung
~18 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top